ClinicalTrials.gg
Not yet recruitingNCT07833605AI-LAXUpdated Sep 22, 2026

AI-Based Video Assessment of Anterior Knee Laxity

An observational study in ACL - Anterior Cruciate Ligament Deficiency, sponsored by ASL Lecce. Not yet recruiting at 1 site in Italy. Open to participants aged 16 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by ASL Lecce · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
16 Years to 55 Years
Sex
All
01

Study summary

This prospective observational validation study aims to evaluate the accuracy and reliability of artificial intelligence-based video analysis for quantifying anterior knee laxity. Participants with unilateral anterior cruciate ligament (ACL) injury and ACL-intact controls will undergo bilateral knee examination using a Rolimeter by two independent orthopedic surgeons. Three consecutive measurements will be obtained for each knee and examiner. Each examination maneuver will be video recorded using a standardized acquisition protocol including a metric reference of known dimensions.

The videos will subsequently be analyzed independently by a multimodal artificial intelligence system blinded to clinical diagnosis, MRI findings, injured side, examiner measurements, and contralateral knee measurements. AI-derived anterior tibial translation and side-to-side difference will be compared with Rolimeter measurements. The primary objective is to assess agreement between AI-derived and Rolimeter-derived side-to-side difference. Secondary objectives include inter-examiner reliability, AI repeatability and the diagnostic accuracy of AI-derived measurements for identifying ACL injury.

Read the detailed description

Each examiner will perform three consecutive Rolimeter measurements on both knees. Individual maneuvers will be video recorded so that the Rolimeter and AI measurements refer to the same mechanical examination. Videos will be pseudonymized and analyzed independently. The AI system will have no access to participant group allocation, MRI findings, injured side, Rolimeter measurements, or results from other videos belonging to the same participant.

A standardized metric reference positioned in the plane of the examined knee will be visible in each recording to permit estimation of displacement in millimeters. AI measurements will not be used for clinical decision-making.

02

Conditions studied

  • ACL - Anterior Cruciate Ligament Deficiency

Keywords

  • ACL
  • AI
  • ARTHROMETER
03

In context

Lead sponsor

ASL Lecce is the lead sponsor of 5 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults undergoing prospective bilateral assessment of anterior knee laxity at a single orthopedic center. The study population will include two cohorts: participants with a unilateral, complete anterior cruciate ligament (ACL) injury confirmed by magnetic resonance imaging and ACL-intact control participants without clinical evidence or history of ACL injury.

All participants will undergo the same standardized bilateral knee examination using an arthrometer performed independently by two orthopedic examiners. Each examination maneuver will be video recorded for subsequent blinded AI-based assessment of anterior tibial translation.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • General inclusion criteria
  • Age ≥16 years.
  • Ability to understand the study procedures and provide written .
  • Ability to undergo bilateral clinical assessment of anterior knee laxity.

ACL-Deficient Group

  • Unilateral complete anterior cruciate ligament (ACL) injury confirmed by magnetic resonance imaging (MRI).
  • Clinical evidence of anterior knee instability compatible with ACL deficiency.
  • Contralateral knee without known ACL injury or previous ACL reconstruction.
  • ACL-Intact Control Group
  • No history of ACL injury or ACL reconstruction in either knee.
  • No clinical evidence of anterior knee instability.
  • Negative clinical assessment for ACL deficiency in both knees.

Exclusion criteria

Exclusion Criteria

  • Previous ACL reconstruction or other major ligament reconstruction of either knee.
  • Bilateral ACL injury.
  • Revision ACL injury or previous ACL surgery.
  • Concomitant complete injury of another major knee ligament requiring surgical treatment.
  • Previous major knee surgery that could affect anterior tibial translation.
  • Moderate-to-severe knee osteoarthritis or radiographic osteoarthritis greater than Kellgren-Lawrence grade 1.
  • Acute fracture involving the examined lower limb.
  • Neurological, neuromuscular, or other conditions that could interfere with standardized knee examination.
  • Inability to tolerate or complete the standardized arthrometer examination.
  • Inability or unwillingness to provide or consent for study video recording.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • ACL-deficient participants

    Adults with a unilateral, complete anterior cruciate ligament (ACL) injury confirmed by magnetic resonance imaging (MRI). Participants will undergo bilateral anterior knee laxity assessment using a Rolimeter by two independent orthopedic examiners. Three consecutive measurements will be obtained for each knee and examiner, and each examination maneuver will be video recorded for subsequent blinded AI-based analysis. The contralateral knee will serve as the within-subject reference for calculation of the side-to-side difference.

  • ACL-Intact Control Group

    Adults without a history or clinical evidence of ACL injury or knee instability. Participants will undergo the same standardized bilateral anterior knee laxity assessment performed by two independent orthopedic examiners using a Rolimeter, with three consecutive measurements for each knee and examiner. Each examination maneuver will be video recorded and subsequently analyzed by the AI system using the same protocol applied to the ACL-deficient cohort.

06

What researchers measure

Primary outcomes

  1. Agreement Between AI-Derived and Arthrometer-Derived Side-to-Side Difference in Anterior Tibial Translation

    Agreement between the side-to-side difference (SSD, mm) in anterior tibial translation estimated by artificial intelligence from standardized knee examination videos and the corresponding SSD obtained with an arthrometer. Agreement will be assessed using intraclass correlation coefficient (ICC, absolute agreement) and Bland-Altman analysis, including mean bias and 95% limits of agreement.

    Time frame: Day 1 (index study examination)

Secondary outcomes

  1. Measurement Error of AI-Derived Anterior Tibial Translation Compared With Arthrometer Measurements

    The difference between AI-derived and arthrometer-derived measurements of anterior tibial translation will be quantified in millimeters using mean absolute error (MAE), root mean square error (RMSE), mean bias, and 95% limits of agreement.

    Time frame: Day 1 (index study examination)

  2. Inter-Examiner Reliability of Arthrometer Measurements

    Reliability of anterior tibial translation and side-to-side difference measurements obtained independently by two orthopedic examiners using an arthrometer. Inter-examiner reliability will be assessed using intraclass correlation coefficients with 95% confidence intervals and Bland-Altman analysis.

    Time frame: Day 1 (index study examination)

  3. Agreement Between AI Measurements Derived From Examinations Performed by Different Examiners

    Agreement between AI-derived anterior tibial translation and side-to-side difference obtained from videos of knee examinations performed independently by the two examiners. This outcome will assess the robustness of AI-derived measurements with respect to examiner-related variability.

    Time frame: Day 1 (index study examination)

  4. Diagnostic Accuracy of AI-Derived Side-to-Side Difference for ACL Injury

    The ability of AI-derived side-to-side difference to discriminate participants with complete anterior cruciate ligament injury from ACL-intact controls will be assessed using receiver operating characteristic (ROC) curve analysis. Area under the curve (AUC), sensitivity, specificity, positive predictive value, and negative predictive value will be calculated.

    Time frame: Day 1 (index study examination)

  5. diagnostic Accuracy of Arthrometer-Derived Side-to-Side Difference for ACL Injury

    The diagnostic performance of arthrometer-derived side-to-side difference for identifying complete anterior cruciate ligament injury will be evaluated using ROC curve analysis, including AUC, sensitivity, specificity, positive predictive value, and negative predictive value.

    Time frame: Day 1 (index study examination)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — De-identified data may be made available from the corresponding author upon reasonable request, subject to institutional and ethical approval.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 12, 2026
First posted
Sep 22, 2026
StartEst.
Sep 15, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Sep 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07833605
Lead sponsor
ASL Lecce
Responsible party
Jacopo Conteduca (Principal Investigator, ASL Lecce) — Principal investigator
First posted
Sep 22, 2026
Start date
Sep 15, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 22, 2026

Study contacts

Jacopo Conteduca, MD
Contact
conteduca85@gmail.com
0039 3332280645

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion